Status:
COMPLETED
Comparison Between Analog Neurocognitive Tests Conducted by a Trained Test Leader Versus Self-administered Digital Tests
Lead Sponsor:
Karolinska Institutet
Conditions:
Neurocognitive Decline
Feasibility
Eligibility:
All Genders
60+ years
Phase:
NA
Brief Summary
The study has a randomized crossover design including qualitative interviews of the participant's test experiences. Healthy participants, ≥60 years are eligible to participate in the study. Cognitive ...
Detailed Description
Study design: Randomized crossover design including qualitative interviews of the test procedures. Participants:The participants are planned to be healthy controls (n=50) comprising men and women of ...
Eligibility Criteria
Inclusion
- \> 59 years of age
- ability to read and speak Swedish,
Exclusion
- suffering from a nervous system disease,
- suffering from a severe psychiatric disorder
- alcoholism
- drug dependence
- severe visual or auditory disorder.
Key Trial Info
Start Date :
February 17 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 5 2022
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05253612
Start Date
February 17 2022
End Date
April 5 2022
Last Update
March 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ulrica Nilsson
Stockholm, Sweden, 141 83